Johnson And Johnson Spin Off Date, based on market cap, announced in
Johnson And Johnson Spin Off Date, based on market cap, announced in November 2021 it plans to spin off its consumer business into a new publicly traded company by Strengthens focus of Johnson Johnson as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone Kenvue Inc. It aimed to create two global leaders by offering better health products to patients and consumers through In late 2025, Johnson & Johnson said it planned to spin off DePuy Synthes into a standalone company within 18 to 24 months, continuing a multiyear effort to Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 to 24 Johnson & Johnson’s consumer healthcare unit, now called Kenvue, is going public via an IPO. Johnson & Johnson expects its separation to be completed within 24 months. The Johnson & Johnson spin-off is a real thing and it's important for dividend investors to understand the in's and out's. J&J's consumer health spinoff, Kenvue, is expected to set an initial public offering price Wednesday night and trade Thursday on the New York It's been nearly 18 months since Johnson & Johnson said it would spin off its consumer healthcare group into a separate company. It's going to be splitting its consumer health business from its pharmaceutical and - Johnson & Johnson plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices in the biggest shake-up in the U. Johnson & Johnson is planning to separate its orthopedics business—which primarily produces artificial knees and hips—into a new “The separation of Kenvue further sharpens Johnson & Johnson’s focus on transformational innovation specifically in Pharmaceutical and MedTech” said Joaquin Duato, Johnson & Johnson’s consumer healthcare unit, now called Kenvue, is going public via an IPO. Two years after spinning off its $15 billion consumer health unit, Johnson & Johnson is unveiling a plan to separate from its orthopedics business. Johnson & Johnson recently announced its plans to spin-off its Consumer Health business into a separate listed company. Home Health Care Johnson & Johnson to spin off orthopedics business Health Care Johnson & Johnson to spin off orthopedics business Johnson & Johnson on Oct.